This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignees: Bia Separations D.o.o., Sveuciliste U Zagrebu. Active years: 2020.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2020
Title: Dubravko Forcic: Innovator in Immunoaffinity Chromatography
Introduction
Dubravko Forcic is a notable inventor based in Zagreb, Croatia. He has made significant contributions to the field of immunoaffinity chromatography, particularly in the purification of viruses. His innovative approach has implications for the production of viral vaccines and vectors.
Latest Patents
Dubravko Forcic holds a patent for an invention titled "Elution mobile phase and process for immunoaffinity chromatography of viruses." This patent discloses a novel composition of the elution mobile phase for virus purification. The composition includes one or more amino acids such as L-serine, L-asparagine, or L-glutamine, along with auxiliary ingredients like L-arginine, glycine, or imidazole. The invention also incorporates pharmaceutically acceptable pH adjusting agents and purified water, making it a comprehensive solution for virus purification. This innovation is crucial for separating infectious from non-infectious viral particles and enriching viral suspensions.
Career Highlights
Throughout his career, Dubravko Forcic has worked with esteemed organizations, including the University of Zagreb and Bia Separations. His work has focused on advancing techniques in immunoaffinity chromatography, contributing to the scientific community's understanding of viral purification processes.
Collaborations
Dubravko has collaborated with notable colleagues such as Marija Brgles and Beata Halassy. Their combined expertise has furthered the development of innovative solutions in the field of virology.
Conclusion
Dubravko Forcic's contributions to immunoaffinity chromatography exemplify the importance of innovation in the field of virology. His patent and collaborative efforts highlight the potential for advancements in viral vaccine production and purification processes.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile